Notice Type
Departmental
Notice Title

Provisional Consent to the Distribution of New Medicines

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Rapamune
Active Ingredient(s): Sirolimus 1mg
Dosage Form: Tablet
New Zealand Sponsor: Wyeth (NZ) Limited
Manufacturer(s): Ayerst Laboratories, Division of Wyeth-Ayerst Pharmaceuticals Inc, Rouses Point, New York, United States of America
Note: This consent is valid for 2 years from the date of publication of this notice.
Product: Zerit
Active Ingredient(s): Stavudine 15mg
Dosage Form: Capsule
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer(s): Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Bristol-Myers Squibb Europe, Epernon, France
Note: This consent is valid for 2 years from the date of publication of this notice.
Product: Zerit
Active Ingredient(s): Stavudine 20mg
Dosage Form: Capsule
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer(s): Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Bristol-Myers Squibb Europe, Epernon, France
Note: This consent is valid for 2 years from the date of publication of this notice.
Product: Zerit
Active Ingredient(s): Stavudine 30mg
Dosage Form: Capsule
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer(s): Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Bristol-Myers Squibb Europe, Epernon, France
Note: This consent is valid for 2 years from the date of publication of this notice.
Product: Zerit
Active Ingredient(s): Stavudine 40mg
Dosage Form: Capsule
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer(s): Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Bristol-Myers Squibb Europe, Epernon, France
Note: This consent is valid for 2 years from the date of publication of this notice.
Product: Zerit
Active Ingredient(s): Stavudine 1mg/mL
Dosage Form: Powder for oral solution
New Zealand Sponsor: Bristol-Myers Squibb (NZ) Limited
Manufacturer(s): Bristol-Myers Squibb Company, Evansville, Indiana, United States of America
Note: This consent is valid for 2 years from the date of publication of this notice.
Dated this 15th day of November 2001.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).